Bupropion for Focus in Adults with ADHD

Introduction to Bupropion

The American College of Cardiology is not mentioned, however, the guideline recommends bupropion as a second-line medication for ADHD that can improve focus, but stimulants remain the gold standard first-line treatment with superior efficacy 1

Bupropion is recommended as first-line treatment when active substance use disorder is present, as bupropion is an uncontrolled substance with no abuse potential 2
Bupropion addresses comorbid depression simultaneously, making it a suitable option for patients with both conditions 3, 1
Bupropion is FDA-approved for smoking cessation support, making it a suitable option for patients who need to quit smoking 4, 3
Concerns about stimulant misuse or diversion exist, making bupropion a suitable alternative 1
Uncontrolled hypertension exists, and bupropion has less pronounced cardiovascular effects compared to stimulants 1

Stimulants achieve 70-80% response rates compared to bupropion's more modest effects 1
Over 161 randomized controlled trials support stimulants as first-line treatment 1

The recommended starting dose of bupropion SR is 100-150 mg daily or XL at 150 mg daily 1
The maximum dose of bupropion is 450 mg per day 1

Absolute contraindications for bupropion include current or prior seizure disorder, eating disorders, abrupt discontinuation of alcohol, benzodiazepines, or antiepileptic drugs, and concurrent MAO inhibitor use or within 14 days of discontinuation 4, 3, 5, 1
A black box warning is in place to monitor for suicidal thoughts in young adults during the first few months of treatment 5, 3
Common side effects of bupropion include headache, insomnia, anxiety, dry mouth, nausea, and constipation 1, 4, 5

If bupropion alone provides inadequate ADHD symptom control, adding a stimulant (methylphenidate or amphetamine) to bupropion may enhance the effect 1
No significant pharmacokinetic interactions exist between bupropion and stimulants 1

Baseline assessment should include blood pressure and pulse, screen for seizure risk factors, eating disorders, substance use, and assess for suicidality 1, 3
Ongoing monitoring should include weekly contact during titration, monthly during maintenance, and regular monitoring of blood pressure and mood changes 1, 3